Organovo Holdings, Inc. financial data

Symbol
ONVO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
11555 Sorrento Valley Road, Suite 100, San Diego, CA
State of incorporation
DE
Fiscal year end
March 31
Former names
REAL ESTATE RESTORATION & RENTAL, INC. (to 10/31/2011)
Latest financial report
10-Q - Q4 2024 - Feb 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 196 % -60.5%
Quick Ratio 14.6 %
Debt-to-equity 84.6 % +164%
Return On Equity -346 % -89.3%
Return On Assets -188 % -35.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.5M shares +73.8%
Common Stock, Shares, Outstanding 17.1M shares +74.1%
Entity Public Float 10.3M USD -38.2%
Common Stock, Value, Issued 17K USD +70%
Weighted Average Number of Shares Outstanding, Basic 18.1M shares +98.1%
Weighted Average Number of Shares Outstanding, Diluted 18.1M shares +98.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 122K USD -49.6%
Research and Development Expense 5.23M USD -47.1%
Costs and Expenses 12.7M USD -36.6%
Operating Income (Loss) -12.6M USD +36.5%
Nonoperating Income (Expense) 175K USD -74.5%
Income Tax Expense (Benefit) 2K USD 0%
Net Income (Loss) Attributable to Parent -12.4M USD +35.1%
Earnings Per Share, Basic -0.84 USD/shares +61.5%
Earnings Per Share, Diluted -0.84 USD/shares +61.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.16M USD -78.1%
Accounts Receivable, after Allowance for Credit Loss, Current 26K USD -21.2%
Inventory, Net 0 USD
Other Assets, Current 4K USD -94.2%
Assets, Current 2.1M USD -66.4%
Property, Plant and Equipment, Net 479K USD -35.2%
Operating Lease, Right-of-Use Asset 978K USD -30.3%
Assets 3.84M USD -56.7%
Accounts Payable, Current 930K USD +97.5%
Employee-related Liabilities, Current 330K USD -24.8%
Accrued Liabilities, Current 1.02M USD +39.6%
Liabilities, Current 2.94M USD +72.8%
Operating Lease, Liability, Noncurrent 543K USD -45.6%
Liabilities 3.48M USD +28.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1K USD 0%
Retained Earnings (Accumulated Deficit) -349M USD -3.68%
Stockholders' Equity Attributable to Parent 364K USD -94.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 364K USD -94.1%
Liabilities and Equity 3.84M USD -56.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.98M USD +43.8%
Net Cash Provided by (Used in) Financing Activities 6.25M USD
Net Cash Provided by (Used in) Investing Activities 20K USD -97.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 17.1M shares +74.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.29M USD
Deferred Tax Assets, Valuation Allowance 2.98M USD +21.4%
Deferred Tax Assets, Gross 3.38M USD +14%
Operating Lease, Liability 1.06M USD -29.4%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.4M USD +35.1%
Lessee, Operating Lease, Liability, to be Paid 1.13M USD -31.5%
Property, Plant and Equipment, Gross 1.93M USD -11.5%
Operating Lease, Liability, Current 517K USD +2.99%
Lessee, Operating Lease, Liability, to be Paid, Year Two 460K USD -14.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 538K USD +2.87%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 71K USD -52.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 538K USD 0%
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 460K USD 0%
Operating Lease, Payments 521K USD +3.37%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 70K USD +4.48%
Deferred Tax Assets, Net of Valuation Allowance 393K USD -22%
Share-based Payment Arrangement, Expense 642K USD -64.5%